Published in J Gen Virol on April 01, 1984
Primary structure of the herpesvirus saimiri genome. J Virol (1992) 5.26
Characterization of the bovine herpesvirus 4 major immediate-early transcript. J Virol (1991) 1.60
Terminal repetitive sequences in herpesvirus saimiri virion DNA. J Virol (1985) 1.51
Genome sequence of bovine herpesvirus 4, a bovine Rhadinovirus, and identification of an origin of DNA replication. J Virol (2001) 1.44
Bovine herpesvirus 4 is tropic for bovine endometrial cells and modulates endocrine function. Reproduction (2007) 1.03
Animal cytomegaloviruses. Microbiol Rev (1990) 1.02
Establishment of a bovine herpesvirus 4 based vector expressing a secreted form of the bovine viral diarrhoea virus structural glycoprotein E2 for immunization purposes. BMC Biotechnol (2007) 0.95
Potential secondary pathogenic role for bovine herpesvirus 4. J Clin Microbiol (2005) 0.89
Recombinant bovine herpesvirus 4 (BoHV-4) expressing glycoprotein D of BoHV-1 is immunogenic and elicits serum-neutralizing antibodies against BoHV-1 in a rabbit model. Clin Vaccine Immunol (2006) 0.83
Herpes simplex virus type 1 thymidine kinase-armed bovine herpesvirus type 4-based vector displays enhanced oncolytic properties in immunocompetent orthotopic syngenic mouse and rat glioma models. Neuro Oncol (2012) 0.83
Detection of bovine herpesvirus 4 (BoHV-4) DNA in the cell fraction of milk of dairy cattle with history of BoHV-4 infection. J Clin Microbiol (2000) 0.79
International uniform response criteria for multiple myeloma. Leukemia (2006) 17.78
Lyme disease spirochetes and ixodid tick spirochetes share a common surface antigenic determinant defined by a monoclonal antibody. Infect Immun (1983) 9.60
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders. Leukemia (2008) 3.41
Disulfide-mediated interactions of the chlamydial major outer membrane protein: role in the differentiation of chlamydiae? J Bacteriol (1985) 3.23
Borna disease: a persistent virus infection of the central nervous system. Prog Med Virol (1988) 2.83
Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma. Leukemia (2007) 2.76
Genomic organization of Borna disease virus. Proc Natl Acad Sci U S A (1994) 2.74
Borna disease virus, a negative-strand RNA virus, transcribes in the nucleus of infected cells. Proc Natl Acad Sci U S A (1992) 2.44
Repetitive sequences in complete and defective genomes of Herpesvirus saimiri. J Virol (1975) 2.36
Borna disease virus genome transcribed and expressed in psychiatric patients. Nat Med (1995) 2.30
The challenge of biosimilars. Ann Oncol (2007) 2.28
The prognostic significance of proliferating cell nuclear antigen, epidermal growth factor receptor, and mdr gene expression in colorectal cancer. Cancer (1993) 2.23
Identification of a common antigen of herpes simplex virus bovine herpes mammillitis virus, and B virus. J Virol (1978) 2.16
Interleukin-6 is a prognostic factor in multiple myeloma. Blood (1991) 2.16
Biotyping of Chlamydia psittaci based on inclusion morphology and response to diethylaminoethyl-dextran and cycloheximide. Infect Immun (1979) 2.10
A viro-psycho-immunological disease-model of a subtype affective disorder. Pharmacopsychiatry (1998) 2.08
Psittacosis-lymphogranuloma infection of sheep. Antigenic structures and interrelations of PL agents associated with polyarthritis, enzootic abortion, intrauterine and latent intestinal infections. J Comp Pathol (1966) 1.94
Structures of and allelic diversity and relationships among the major outer membrane protein (ompA) genes of the four chlamydial species. J Bacteriol (1993) 1.90
Presence of a p53 gene deletion in patients with multiple myeloma predicts for short survival after conventional-dose chemotherapy. Blood (1998) 1.90
Dextran sulphate 500 delays and prevents mouse scrapie by impairment of agent replication in spleen. J Gen Virol (1984) 1.87
Physicochemical properties of the DNA of herpes viruses. Biochim Biophys Acta (1972) 1.86
Antigenic diversity of Chlamydia psittaci of mammalian origin determined by microimmunofluorescence. Infect Immun (1985) 1.84
First isolates of infectious human Borna disease virus from patients with mood disorders. Mol Psychiatry (1996) 1.83
Serotyping of Chlamydia. I. Isolates of ovine origin. Infect Immun (1974) 1.76
A simple method for measuring red cell deformability in models of the microcirculation. Blut (1973) 1.75
Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group. Leukemia (2012) 1.74
Ultrastructural cytochemical evidence for the activation of lysosomes in the cytocidal effect of Chlamydia psittaci. Infect Immun (1975) 1.72
Sequence conservation in field and experimental isolates of Borna disease virus. J Virol (1994) 1.67
Arrangement of pili in colonies of Neisseria gonorrhoeae. J Bacteriol (1984) 1.66
Detection of new DNA polymerase genes of known and potentially novel herpesviruses by PCR with degenerate and deoxyinosine-substituted primers. Virus Genes (1999) 1.65
Amantadine and human Borna disease virus in vitro and in vivo in an infected patient with bipolar depression. Lancet (1997) 1.62
Persistent, tolerant or subacute infection in Borna disease virus-infected rats. J Gen Virol (1983) 1.62
Cerebrovascular tone rather than intracranial pressure determines the effective downstream pressure of the cerebral circulation in the absence of intracranial hypertension. J Neurosurg Anesthesiol (2000) 1.61
Serotyping of Chlamydia: isolates of bovine origin. Infect Immun (1975) 1.61
Clp-mediated proteolysis in Gram-positive bacteria is autoregulated by the stability of a repressor. EMBO J (2001) 1.61
Borna disease--neuropathology and pathogenesis. Curr Top Microbiol Immunol (1995) 1.59
Borna disease virus-specific antibodies in patients with HIV infection and with mental disorders. Lancet (1988) 1.57
RNA turnover in Trypanosoma brucei. Mol Cell Biol (1987) 1.51
Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2013) 1.47
Erythropoiesis-stimulating agents in oncology: a study-level meta-analysis of survival and other safety outcomes. Br J Cancer (2010) 1.46
Chemoprophylaxis of scrapie in mice. J Gen Virol (1991) 1.45
The interaction of Chlamydia trachomatis with host cells: ultrastructural studies of the mechanism of release of a biovar II strain from HeLa 229 cells. J Infect Dis (1985) 1.44
Genome sequence of bovine herpesvirus 4, a bovine Rhadinovirus, and identification of an origin of DNA replication. J Virol (2001) 1.44
Two-step polymerase chain reactions and restriction endonuclease analyses detect and differentiate ompA DNA of Chlamydia spp. J Clin Microbiol (1992) 1.42
Pathogenesis and treatment of renal failure in multiple myeloma. Leukemia (2008) 1.42
Action of penicillin on Borrelia hermsii. Antimicrob Agents Chemother (1982) 1.42
Immunologic and genetic relationship between herpes simplex virus and bovine herpes mammillitis virus. Intervirology (1974) 1.41
Interferon-alpha treatment in multiple myeloma: meta-analysis of 30 randomised trials among 3948 patients. Ann Oncol (2000) 1.39
Modeling of treatment response to erythropoiesis-stimulating agents as a function of center- and patient-related variables: results from the Anemia Cancer Treatment (ACT) study. Ann Oncol (2009) 1.39
A novel herpesvirus in the sanctuary chimpanzees on Ngamba Island in Uganda. J Med Primatol (2009) 1.38
Biological properties of rabbit antibodies to a surface antigen of Rickettsia rickettsii. Infect Immun (1983) 1.37
Specificity of cleavage in replicative-form DNA of bovine herpesvirus 1. J Virol (1988) 1.34
Borna disease in ostriches. Vet Rec (1993) 1.34
Comparison of genomic and predicted amino acid sequences of respiratory and enteric bovine coronaviruses isolated from the same animal with fatal shipping pneumonia. J Gen Virol (2001) 1.34
Detection and multigenic characterization of a novel gammaherpesvirus in goats. Virus Res (2001) 1.33
Mode of entry and release of chlamydiae in infections of intestinal epithelial cells. J Infect Dis (1972) 1.33
Studies on the relatedness of herpes viruses through DNA-RNA hybridization. Biochim Biophys Acta (1972) 1.31
Prevalence and management of cancer-related anaemia, iron deficiency and the specific role of i.v. iron. Ann Oncol (2012) 1.31
Immunoprecipitation of herpes simplex virus type 1 antigens with different antisera and human cerebrospinal fluids. Arch Virol (1977) 1.30
International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation. Leukemia (2009) 1.29
Efficient production of single-stranded DNA as long as 2 kb for sequencing of PCR-amplified DNA. Biotechniques (1992) 1.29
[Borna virus infection (Borna disease) in naturally and experimentally infected animals: its significance for research and practice]. Tierarztl Prax (1985) 1.29
Behavior alterations in tree shrews (Tupaia glis, Diard 1820) induced by Borna disease virus. Med Microbiol Immunol (1978) 1.29
Analysis of herpes simplex virus type 1 antigens exposed on the surface of infected tissue culture cells. Virology (1978) 1.28
Chlamydia psittaci: growth characteristics and enumeration of serotypes 1 and 2 in cultured cells. J Infect Dis (1979) 1.26
Quality of life in chronic anemia of cancer during treatment with recombinant human erythropoietin. Cancer (1994) 1.25
The characterization of Varicella-zoster virus DNA. J Gen Virol (1972) 1.23
Adaptation of Borna disease virus to the mouse. J Gen Virol (1984) 1.23
Human infections with Borna disease virus: seroprevalence in patients with chronic diseases and healthy individuals. J Med Virol (1992) 1.22
Bortezomib in relapsed multiple myeloma: response rates and duration of response are independent of a chromosome 13q-deletion. Leukemia (2006) 1.22
Cloning and sequencing of columbid circovirus (coCV), a new circovirus from pigeons. Arch Virol (2000) 1.20
Increase of virus yields and releases of Borna disease virus from persistently infected cells. Virus Res (1985) 1.20
Natural Borna disease in domestic animals others than horses and sheep. Zentralbl Veterinarmed B (1993) 1.18
Biological and genetic characterization of a hemagglutinating coronavirus isolated from a diarrhoeic child. J Med Virol (1994) 1.18
The ionic properties of the filamentous bacteriophages Pf1 and fd. J Biol Chem (1986) 1.18
[Autoimmune phenomena in D-penicillamine therapy]. Acta Med Austriaca (1975) 1.17
Optimizing the use of lenalidomide in relapsed or refractory multiple myeloma: consensus statement. Leukemia (2011) 1.17
Towards purification of the scrapie agent. Eur J Biochem (1983) 1.17
Isolation and characterization of a 14500 molecular weight protein from brains and tissue cultures persistently infected with borna disease virus. J Gen Virol (1985) 1.17
Small in-frame deletions and missense mutations in CADASIL: 3D models predict misfolding of Notch3 EGF-like repeat domains. Eur J Hum Genet (2000) 1.17
Interferon-alpha stimulates the hypothalamic-pituitary-adrenal axis in vivo and in vitro. Neuroendocrinology (1993) 1.16
Isolation of a psittacosis agent (Chlamydia) from semen and epididymis of bulls with seminal vesiculitis syndrome. Am J Vet Res (1968) 1.16
Sequence characterization of human Borna disease virus. Virus Res (1996) 1.15
Learning deficiencies in Borna disease virus-infected but clinically healthy rats. Biol Psychiatry (1989) 1.15
Inhibition of herpes virus-induced cell fusion by concanavalin A, antisera, and 2-deoxy-D-glucose. J Virol (1974) 1.14
Interleukin-6 and tumor necrosis factor alpha levels after bisphosphonates treatment in vitro and in patients with malignancy. Bone (1996) 1.14
Treponema infection associated with genital ulceration in wild baboons. Vet Pathol (2011) 1.13
Borna disease in rhesus monkeys as a models for uveo-cerebral symptoms. J Med Virol (1981) 1.13
Enhancement of plaque formation and cell fusion of an enteropathogenic coronavirus by trypsin treatment. Infect Immun (1981) 1.12
[Surface structure of the human placenta in the scanning electron microscope]. Arch Gynakol (1971) 1.12
Modified vaccinia virus Ankara protein F1L is a novel BH3-domain-binding protein and acts together with the early viral protein E3L to block virus-associated apoptosis. Cell Death Differ (2006) 1.11
[Anticoagulants in the radiotherapy of genital carcinomas in women. I. Squamous cell carcinoma]. Med Welt (1968) 1.09
Humoral immunodeficiency to bacterial antigens in patients with juvenile onset diabetes mellitus. Diabetologia (1976) 1.08
Polyarthritis of calves: isolation of psittacosis agents from affected joints. Am J Vet Res (1966) 1.07
Inapparent respiratory infection of inbred Swiss mice with sulfadiazine-resistant, iodine-negative Chlamydiae. Infect Immun (1971) 1.07
The reticuloendothelial system in scrapie pathogenesis. J Gen Virol (1984) 1.06